Navigation Links
TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
Date:5/22/2008

SAN MARINO, Calif., May 22 /PRNewswire/ -- Epeius Biotechnologies announced today the promising results of an on-going United States-based Phase I/II study of Rexin-G for metastatic breast cancer that is refractory to conventional chemotherapy (J Clin Oncol 26:14509, 2008). This clinical trial employed intra-patient dose-escalations of Rexin-G given i.v. two to three times a week for 4 weeks, with doses ranging from 2 x 10e11 cfu to 6 x 10e11 cfu per week. The goal of the adaptive trial design is to confirm the over-all safety of Rexin-G and to determine the optimal dosing regimen for Rexin-G that would document the significant clinical benefits required to support a Phase II pivotal study.

The interim results of this Phase I/II study of targeted gene delivery in vivo are very encouraging -- intravenous infusions of Rexin-G demonstrated significant biological activity without toxicity in patients with rapidly progressive chemo-resistant breast cancer. Once the general safety of repeated infusions of Rexin-G was documented, the FDA approved across the board intra-patient dose-escalations in order to gain better tumor control. These escalating doses of Rexin-G were associated with stabilization of disease, using both RECIST and International PET criteria, significant reductions in CA 15.3 levels, a median progression-free survival of 6 months (RECIST) and a median over-all survival of greater than 7 months with all patients surviving at the 8-month follow-up period. No dose-limiting toxicity was observed, even at the higher doses of Rexin-G, thus confirming that repeated infusions of Rexin-G are safe and well-tolerated.

According to Dr. Erlinda M. Gordon, Medical Director of Epeius, "The importance of these dose-escalation studies -- which clearly establish safety before escalating to more potent tumoricidal levels -- is a primary concern in the development of a new genetic medicine like Rexin-G." Taken together with the results of previous studie
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
2. Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
3. Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma
4. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
5. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
6. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
7. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
8. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
9. ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
10. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
11. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
(Date:7/31/2014)... and VIENNA , July 31, ... a press conference in New York ... a vaccine against Parkinson,s disease. PD01A is the first therapy ... enter clinical testing. The Michael J. Fox Foundation ... 1.5 million grant, and presented at the press conference on ...
(Date:7/31/2014)... and LONDON , July 31, 2014 ... provider for the medical industries, announced today the incorporation of genae ... United Kingdom has one of the largest medical ... billion in 2012 and it is projected to increase by a ... 234 billion in 2012, equal to 9.5% of GDP. Despite recessionary ...
Breaking Medicine Technology:Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4genae Opens Offices in London 2
... NEW YORK, April 14, 2011 Reportlinker.com announces ... in its catalogue: Macular Degeneration ... http://www.reportlinker.com/p0472337/Macular-Degeneration-Therapy-Area-Pipeline-Report.html The Macular Degeneration Therapy ... macular degeneration drug pipeline. This report provides insight ...
... April 13, 2011 RushCard announced today that money-saving ... members.  The plans allow for savings on a variety ... diabetes management products, lab services and more. ... health care offerings, bringing unmatched value to RushCard members. ...
Cached Medicine Technology:Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report 2Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report 3RushCard Offers Members Exclusive Discounts on Health Care Services 2
(Date:7/31/2014)... Adventist Health System, which is ... Florida Hospital Tampa, Florida Hospital Carrollwood, Florida Hospital ... Pinellas, Florida Hospital Wesley Chapel, Florida Hospital Zephyrhills, ... Heartland Medical Center Lake Placid and Florida Hospital ... Most Wired Hospitals and Health Systems, which is ...
(Date:7/31/2014)... The vineyards are lush, and the grapes ... to celebrate, folks are gearing up for the annual ... 7, 2014 along the Leelanau Peninsula Wine Trail . ... run through the vineyards start-ing at 9:00 a.m. on Saturday ... course between rows of grapevines offers an experience like no ...
(Date:7/31/2014)... 2014 Weblify has finally been released by ... development and testing. The result is a perfected and ... little as 5 minutes without knowing any HTML or other ... Shane Michaels, an SEO expert, agrees that this platform allows ... a lot of web site builders out there, but this ...
(Date:7/31/2014)... 2014 United Theological Seminary is pleased ... Le Donne and Peter J. Bellini. Both began their ... United is a Director of Non-Degree Programs, Mark Abbott, ... Anthony Le Donne, Assistant Professor of New Testament, received ... New Testament, Second Temple Judaism, and Greek courses. His ...
(Date:7/31/2014)... NEWwoodworks, fine woodworking group at ... presence with a website dedicated to highlighting their craft ... specialized in handcrafted cabinetry, furniture, stairs , doors, ... a reputation for taking on the remarkable, challenging projects ... craft with reclaimed wood, often using near extinct species ...
Breaking Medicine News(10 mins):Health News:Florida Hospital West Florida Region is Among the Most Wired Hospitals and Health Systems in the United States 2Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers a Unique Vineyard Course for Walkers, Runners and Wine Tasters 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3Health News:Growing Seminary Welcomes New Faculty 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3
... ... informs consumers how to dispute inaccuracies in their credit file , ... Delray Beach, FL (PRWEB) February 9, ... today announced the importance of ensuring a clean credit report and reminds consumers of ...
... should consider preventive measures, study suggests , TUESDAY, Feb. 9 ... much more likely to develop blood clots than people without ... make preventive drug treatment necessary, it adds. , The study, ... who had inflammatory bowel disease (IBD) with 71,672 people who ...
... ... Exploration Summer Programs , open to students around the world, is offering ... 6 to 9, providing an in-depth experience in the culinary arts, emergency ... Exploration Focus Programs will give kids an opportunity to spend ...
... , ... Heart Association’s Go Red For Women® Movement to Fight Heart Disease in Eastern Washington ... Eastern Washington ... Walla Walla, Clarkston, Hermiston, OR, Lewiston, ID announce their participation in year three of ...
... Mich. , Feb. 9 People with depression ... even when they are treated with antidepressants, according to a ... Environmental Medicine. , The study, led by researchers from ... data for more than 22,000 patients diagnosed with depression and ...
... ... applications in iTunes, Healthcare & Fitness category , ... San Francisco (PRWEB) February 9, 2010 -- Abvio demonstrates the ... and Walkmeter , at Macworld 2010 . All three are among the top ...
Cached Medicine News:Health News:NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010 2Health News:Inflammatory Bowel Ups Risk for Blood Clots 2Health News:Time to 'Get Focused' at Exploration Summer Programs 2Health News:Time to 'Get Focused' at Exploration Summer Programs 3Health News:Time to 'Get Focused' at Exploration Summer Programs 4Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 2Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 3Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 4Health News:Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study 2Health News:Media Alert: Abvio Demonstrates Innovative iPhone 3G/3GS Fitness Applications for Running, Cycling and Walking at Macworld 2010 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: